Company · CIK 0000748592 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Ernexa Therapeutics Inc. · ERNA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 AForm 4 → | Sep 1, 9:59 pm EDT | James Arthur BristolDirector | 13,403 | — | — | 5,083 | — | |
| Aug 31, 2026 AForm 4 → | Sep 1, 9:56 pm EDT | Peter CicalaDirector | 11,026 | — | — | 5,083 | — | |
| Aug 31, 2026 AForm 4 → | Sep 1, 9:49 pm EDT | David PolinskyDirector | 5,083 | — | — | 5,083 | — | |
| Aug 31, 2026 AForm 4 → | Sep 1, 9:48 pm EDT | William A. WexlerDirector | 5,943 | — | — | 5,943 | — | |
| Aug 31, 2026 AForm 4 → | Sep 1, 9:47 pm EDT | Elena RatnerDirector | 5,944 | — | — | 5,944 | — | |
| Aug 31, 2026 AForm 4 → | Sep 1, 9:46 pm EDT | Sanjeev LutherPresident and CEO, Director | 118,848 | — | — | 118,848 | — |